Edition:
United Kingdom

Denali Therapeutics Inc (DNLI.OQ)

DNLI.OQ on NASDAQ Stock Exchange Global Select Market

21.56USD
22 Jan 2018
Change (% chg)

$1.80 (+9.11%)
Prev Close
$19.76
Open
$19.80
Day's High
$23.00
Day's Low
$19.80
Volume
122,068
Avg. Vol
--
52-wk High
$23.00
52-wk Low
$14.80

Chart for

About

Denali Therapeutics Inc. is a biotechnology company. The Company is focused on the discovery and development of therapies for patients with neurodegenerative disease, including Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis (ALS) and others. The Company is developing a diversified portfolio of therapeuti... (more)

Overall

No Ratios Available.

Financials

  Industry Sector
P/E (TTM): -- 85.70 16.58
EPS (TTM): -- -- --
ROI: -- 3.19 10.60
ROE: -- 4.52 14.19

BRIEF-Takeda And Denali Therapeutics Collaborate To Develop Therapies For Neurodegenerative Diseases

* TAKEDA AND DENALI THERAPEUTICS COLLABORATE TO DEVELOP AND COMMERCIALIZE THERAPIES FOR NEURODEGENERATIVE DISEASES

05 Jan 2018

BRIEF-Denali Therapeutics Says Initial Public Offering Of 13.9 Mln Common Shares Priced At $18 per Share

* DENALI THERAPEUTICS ANNOUNCES PRICING OF INITIAL PUBLIC OFFERING

08 Dec 2017

BRIEF-Denali Therapeutics Now Sees IPO Of 13.9 Million Shares Priced Between $17-$19 Per Share

* DENALI THERAPEUTICS INC SEES IPO OF 13.9 MILLION SHARES OF ITS COMMON STOCK PRICED BETWEEN $17.00 AND $19.00 PER SHARE - SEC FILING

07 Dec 2017

Earnings vs. Estimates